Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study

Both SD and RD single fraction preoperative SRS demonstrate excellent rates of cavity LR and ARE. Cavity LR risk increased with larger lesion size, regardless of SRS dose category. There does not seem to be an advantage in efficacy or toxicity for RD over SD single fraction preoperative SRS. Additional studies are warranted to optimize preoperative SRS dose and fractionation.

Authors

Institutions

Publication Details

Journal
Advances in Radiation Oncology
Published
2025-04-19
DOI
https://doi.org/10.1016/j.adro.2025.101794
Citations
1
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study

Cristian Udovicich, Susan Boyles, Kailin Yang, Jennifer K. Matsui et al.
1 citations
Advances in Radiation Oncology
Brain Metastases and Treatment
1.52
article

Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study

Cristian Udovicich, Susan Boyles, Kailin Yang, Jennifer K. Matsui, Joshua D. Palmer, Mark Vikas Mishra, Alexander Ksendzovsky, Haley Kopp Perlow, Samuel T. Chao, Tu Dan, Roshan S. Prabhu, Erin S. Murphy, Zachary Vaslow, Graeme F. Woodworth, Zabi Wardak, Anthony L. Asher, Toral Patel, Rachel Russek, Neda Haghighi, Stuart H. Burri
article en
1 citations

Abstract

Both SD and RD single fraction preoperative SRS demonstrate excellent rates of cavity LR and ARE. Cavity LR risk increased with larger lesion size, regardless of SRS dose category. There does not seem to be an advantage in efficacy or toxicity for RD over SD single fraction preoperative SRS. Additional studies are warranted to optimize preoperative SRS dose and fractionation.

Advances in Radiation OncologyVol. 10(7)
University of Maryland, Baltimore (US), Cone Health (US), Cleveland Clinic (US), Epworth Hospital (AU), Peter MacCallum Cancer Centre (AU), Carolina Neurosurgery and Spine Associates (US), Levine Cancer Institute (US), Southeast Radiation Oncology Group (US), U-M Rogel Cancer Center (US), The Ohio State University (US), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 20%
Brain Metastases and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.